Biomarkers in heart failure

被引：0

作者：

Jerez Castro, Ana M. ^{[1
,2
]}

机构：

[1] Inst Cardiol & Cirugia Cardiovasc, Dept Docencia & Invest, Havana, Cuba

[2] Grp Cubano Falla Cardiaca, Havana, Cuba

来源：

CORSALUD | 2019年 / 11卷 / 04期

关键词：

Heart failure; Cardiac biomarkers; Diagnosis; Prognosis; NATRIURETIC PEPTIDES; SOLUBLE ST2; DIAGNOSIS; GUIDELINES; UPDATE;

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

Heart failure is an increasingly prevalent disease, which requires additional blood tests that not only confirm what is clinically presumed, but also be useful in the prognostic evaluation of those who suffer from it. In this context, biomarkers with practical utility appeared in the heart failure guidelines, at the beginning of the year 2000. With diagnostic, prognostic and evolutionary indications in each clinical stage of this disease, both in acute and chronic stages, its use draws guidelines and strategies in the adequate treatment of these patients. In this review article, a brief approach to the subject is made.

引用

页码：317 / 325

页数：9

共 28 条

[1] Pharmacogenomics of the Natriuretic Peptide System in Heart Failure [J].

Abuzaanona A. ;

Lanfear D. .

Current Heart Failure Reports, 2017, 14 (6) :536-542

[2] Echo- and B-Type Natriuretic Peptide-Guided Follow-Up versus Symptom-Guided Follow-Up: Comparison of the Outcome in Ambulatory Heart Failure Patients [J].

Bajraktari, Gani ;

Pugliese, Nicola Riccardo ;

D'Agostino, Andreina ;

Rosa, Gian Marco ;

Ibrahimi, Pranvera ;

Percuku, Luan ;

Miccoli, Mario ;

Galeotti, Gian Giacomo ;

Fabiani, Iacopo ;

Pedrinelli, Roberto ;

Henein, Michael ;

Dini, Frank L. .

CARDIOLOGY RESEARCH AND PRACTICE, 2018, 2018

[3] Biomarkers in heart failure [J].

Braunwald, Eugene .

NEW ENGLAND JOURNAL OF MEDICINE, 2008, 358 (20) :2148-2159

[4] More than a simple biomarker: the role of NGAL in cardiovascular and renal diseases [J].

Buonafine, Mathieu ;

Martinez-Martinez, Ernesto ;

Jaisser, Frederic .

CLINICAL SCIENCE, 2018, 132 (09) :909-923

[5]

D'Alessandro R, 2013, FUTUR CARDIOL, V9, P519, DOI [10.2217/fca.13.32, 10.2217/FCA.13.32]

[6] Comparison between admission natriuretic peptides, NGAL and sST2 testing for the prediction of worsening renal function in patients with acutely decompensated heart failure [J].

De Berardinis, Benedetta ;

Gaggin, Hanna K. ;

Magrini, Laura ;

Belcher, Arianna ;

Zancla, Benedetta ;

Femia, Alexandra ;

Simon, Mandy ;

Motiwala, Shweta ;

Bhardwaj, Anju ;

Parry, Blair A. ;

Nagurney, John T. ;

Coudriou, Charles ;

Legrand, Matthieu ;

Sadoune, Malha ;

Di Somma, Salvatore ;

Januzzi, James L., Jr. .

CLINICAL CHEMISTRY AND LABORATORY MEDICINE, 2015, 53 (04) :613-621

[7]

Espinoza Silva C, 2013, SALUD CARDIOVASCULAR

[8] High-Sensitivity Troponin I in Hospitalized and Ambulatory Patients With Heart Failure With Preserved Ejection Fraction: Insights From the Heart Failure Clinical Research Network [J].

Fudim, Marat ;

Ambrosy, Andrew P. ;

Sun, Lie-Lena ;

Anstrom, Kevin J. ;

Bart, Bradley A. ;

Butler, Javed ;

AbouEzzeddine, Omar ;

Greene, Stephen J. ;

Mentz, Robert J. ;

Redfield, Margaret M. ;

Reddy, Yogesh Nv ;

Vaduganathan, Muthiah ;

Braunwald, Eugene ;

Hernandez, Adrian F. ;

Borlaug, Barry A. ;

Felker, Michael .

JOURNAL OF THE AMERICAN HEART ASSOCIATION, 2018, 7 (24)

[9] Galectin-3 in Heart Failure An Update of the Last 3 Years [J].

Gehlken, Carolin ;

Suthahar, Navin ;

Meijers, Wouter C. ;

de Boer, Rudolf A. .

HEART FAILURE CLINICS, 2018, 14 (01) :75-+

[10] N-acteyl-β-D-glucosaminidase and kidney injury molecule-1: New predictors for long-term progression of chronic kidney disease in patients with heart failure [J].

Jungbauer, Carsten G. ;

Uecer, Ekrem ;

Stadler, Stefan ;

Birner, Christoph ;

Buchner, Stefan ;

Maier, Lars S. ;

Luchner, Andreas .

NEPHROLOGY, 2016, 21 (06) :490-498

← 1 2 3 →